However, in 2004 the Prostate Cancer Prevention Trial (PCPT) challenged this standard by reporting that PCa diagnosed with a Gleason score 7 or higher was detected in 15% of men with PSA <4.0 ng/mL. Here, KLK3 is linked to prostate cancer.